These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 20833132)
21. Upregulation of transient receptor potential vanilloid type-1 receptor expression in oral lichen planus. Bán A; Marincsák R; Bíró T; Perkecz A; Gömöri E; Sándor K; Tóth IB; Bánvölgyi A; Szolcsányi J; Pintér E Neuroimmunomodulation; 2010; 17(2):103-8. PubMed ID: 19923855 [TBL] [Abstract][Full Text] [Related]
22. Expression of transient receptor potential vanilloid 1 (TRPV1) and 2 (TRPV2) in human peripheral blood. Saunders CI; Kunde DA; Crawford A; Geraghty DP Mol Immunol; 2007 Feb; 44(6):1429-35. PubMed ID: 16777226 [TBL] [Abstract][Full Text] [Related]
23. Excessive hypertension and end-organ damage in a transgenic mouse line carrying the rat angiotensinogen gene. Xu P; Wang Y; Sterner-Kock A; Bader M; Schultheiss HP; Walther T J Cardiovasc Pharmacol; 2009 Jan; 53(1):38-43. PubMed ID: 19129738 [TBL] [Abstract][Full Text] [Related]
24. Contribution of transient receptor potential vanilloid subfamily 1 to endothelin-1-induced thermal hyperalgesia. Kawamata T; Ji W; Yamamoto J; Niiyama Y; Furuse S; Namiki A Neuroscience; 2008 Jun; 154(3):1067-76. PubMed ID: 18495351 [TBL] [Abstract][Full Text] [Related]
25. Involvement of transient receptor potential vanilloid 1 receptors in protease-activated receptor-2-induced joint inflammation and nociception. Helyes Z; Sándor K; Borbély E; Tékus V; Pintér E; Elekes K; Tóth DM; Szolcsányi J; McDougall JJ Eur J Pain; 2010 Apr; 14(4):351-8. PubMed ID: 19683949 [TBL] [Abstract][Full Text] [Related]
26. An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy. Zhai P; Galeotti J; Liu J; Holle E; Yu X; Wagner T; Sadoshima J Circ Res; 2006 Sep; 99(5):528-36. PubMed ID: 16902180 [TBL] [Abstract][Full Text] [Related]
27. Myocardial hypertrophy in transgenic mice overexpressing human interleukin 1alpha. Isoda K; Kamezawa Y; Tada N; Sato M; Ohsuzu F J Card Fail; 2001 Dec; 7(4):355-64. PubMed ID: 11782860 [TBL] [Abstract][Full Text] [Related]
28. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure. Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042 [TBL] [Abstract][Full Text] [Related]
29. Transgenic mice with cardiac-specific over-expression of MLK7 have increased mortality when exposed to chronic beta-adrenergic stimulation. Christe M; Jin N; Wang X; Gould KE; Iversen PW; Yu X; Lorenz JN; Kadambi V; Zuckerman SH; Bloem LJ J Mol Cell Cardiol; 2004 Sep; 37(3):705-15. PubMed ID: 15350844 [TBL] [Abstract][Full Text] [Related]
30. 5-Iodoresiniferatoxin evokes hypothermia in mice and is a partial transient receptor potential vanilloid 1 agonist in vitro. Shimizu I; Iida T; Horiuchi N; Caterina MJ J Pharmacol Exp Ther; 2005 Sep; 314(3):1378-85. PubMed ID: 15947039 [TBL] [Abstract][Full Text] [Related]
31. Contribution of TRPV1 to the bradykinin-evoked nociceptive behavior and excitation of cutaneous sensory neurons. Katanosaka K; Banik RK; Giron R; Higashi T; Tominaga M; Mizumura K Neurosci Res; 2008 Nov; 62(3):168-75. PubMed ID: 18789982 [TBL] [Abstract][Full Text] [Related]
32. Transgenic overexpression of transient receptor potential vanilloid subtype 1 attenuates isoproterenol-induced myocardial fibrosis in mice. Wang Q; Zhang Y; Li D; Zhang Y; Tang B; Li G; Yang Y; Yang D Int J Mol Med; 2016 Aug; 38(2):601-9. PubMed ID: 27314441 [TBL] [Abstract][Full Text] [Related]
33. Transient receptor potential vanilloid 1-expressing cardiac afferent nerves may contribute to cardiac hypertrophy in accompany with an increased expression of brain-derived neurotrophic factor within nucleus tractus solitarius in a pressure overload model. Shibata R; Shinohara K; Ikeda S; Iyonaga T; Matsuura T; Kashihara S; Ito K; Kishi T; Hirooka Y; Tsutsui H Clin Exp Hypertens; 2022 Apr; 44(3):249-257. PubMed ID: 35060414 [TBL] [Abstract][Full Text] [Related]
34. Successful TRPV1 antagonist treatment for cardiac hypertrophy and heart failure in mice. Horton JS; Buckley CL; Stokes AJ Channels (Austin); 2013 Jan; 7(1):17-22. PubMed ID: 23221478 [TBL] [Abstract][Full Text] [Related]
35. Expression of TRPV1 in the C57BL/6 mice brain hippocampus and cortex during development. Huang WX; Min JW; Liu YQ; He XH; Peng BW Neuroreport; 2014 Apr; 25(6):379-85. PubMed ID: 24488030 [TBL] [Abstract][Full Text] [Related]
36. Ablation of TRPV1 Elevates Nocturnal Blood Pressure in Western Diet-fed Mice. Zhong B; Ma S; Wang DH Curr Hypertens Rev; 2019; 15(2):144-153. PubMed ID: 30381083 [TBL] [Abstract][Full Text] [Related]
37. TRPV1 Regulates Stress Responses through HDAC2. Wang SE; Ko SY; Jo S; Choi M; Lee SH; Jo HR; Seo JY; Lee SH; Kim YS; Jung SJ; Son H Cell Rep; 2017 Apr; 19(2):401-412. PubMed ID: 28402861 [TBL] [Abstract][Full Text] [Related]
38. Does Transient Receptor Potential Vanilloid Type 1 Alleviate or Aggravate Pathological Myocardial Hypertrophy? Yan Q; Tang J; Zhang X; Wu L; Xu Y; Wang L Front Pharmacol; 2021; 12():681286. PubMed ID: 34040539 [TBL] [Abstract][Full Text] [Related]
39. Transient receptor potential vanilloid subtype 1: A potential therapeutic target for fibrotic diseases. Peng G; Tang X; Gui Y; Yang J; Ye L; Wu L; Ding YH; Wang L Front Physiol; 2022; 13():951980. PubMed ID: 36045746 [TBL] [Abstract][Full Text] [Related]
40. Role of Known Transient Receptor Potential Vanilloid Channels in Modulating Cardiac Mechanobiology. Miller M; Koch SE; Veteto A; Domeier T; Rubinstein J Front Physiol; 2021; 12():734113. PubMed ID: 34867442 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]